79 results match your criteria: "Centre mémoire ressources et recherche[Affiliation]"

Aβ42 biomarker linked to insula, striatum, thalamus and claustrum in dementia with Lewy bodies.

Geroscience

January 2025

ICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS Team and IRIS Platform, University of Strasbourg and CNRS, Strasbourg, France.

The differential mechanisms between proteinopathies and neurodegeneration in Alzheimer's disease (AD) and dementia with Lewy bodies (DLB) remain unclear. To address this issue, we conducted a voxel-based morphometry and cerebrospinal fluid biomarker (α-synuclein, Aβ42, t-Tau and p-Tau) level correlation study in patients with DLB, AD and mixed cases (AD + DLB). Cerebrospinal fluid samples obtained by lumbar puncture and whole-brain T1-weighted images were collected in the AlphaLewyMA cohort.

View Article and Find Full Text PDF

Usefulness of Cerebrospinal Fluid Alzheimer's disease biomarkers in older patients: Evidence from a national multicenter prospective study.

J Prev Alzheimers Dis

January 2025

Geriatrics Department, Fernand Widal Lariboisière University Hospital, GHU APHP.Nord, Paris, France; Paris-Cité University, Inserm U1144, Paris, France; Paris-Cité University, Inserm U1153, Paris, France.

Background: The use of cerebrospinal (CSF) biomarkers in the diagnosis of Alzheimer's disease (AD) has been gaining interest in clinical practice. Although their usefulness has been demonstrated, their potential value in older patients remains debated.

Objectives: To assess whether knowledge of the results of CSF AD biomarkers was associated with the same gain in diagnostic confidence in older adults > 80 than in younger patients.

View Article and Find Full Text PDF

Candida albicans strains adapted to the mouse gut are resistant to bile salts via a Flo8-dependent mechanism.

Fungal Genet Biol

December 2024

Departamento de Microbiología y Parasitología-IRYCIS, Facultad de Farmacia, Universidad Complutense de Madrid, Avda. Ramón y Cajal s/n, 28040 Madrid, Spain. Electronic address:

Candidaalbicans normally colonizes the human gastrointestinal tract as a commensal. Studying fungal factors involved in colonizing the mammalian gastrointestinal tract requires mouse models with altered microbiota. We have obtained strains of C.

View Article and Find Full Text PDF

Chronic dextroamphetamine abuse and dementia with Lewy bodies: Case report.

Encephale

October 2024

EA4468-Maladie d'Alzheimer et apparentées; Diagnostic, interventons et technologie, Paris Cité University, 75013 Paris, France; Geriatric Department 1&2, Resources and Research Memory Center (centre mémoire de ressources et recherche), Île-de-France Sud - Broca, Assistance publique-Hôpitaux de Paris, Paris, France; Geriatrics, Broca Hospital, 54-56, rue Pascal, 75013 Paris, France. Electronic address:

View Article and Find Full Text PDF

Organization of conceptual tool knowledge following left and right brain lesions: Evidence from neuropsychological dissociations and multivariate disconnectome symptom mapping.

Brain Cogn

November 2024

Université de Franche-Comté, UMR INSERM 1322 LINC, F-25000, Besançon, France; Unité de Neurologie Vasculaire (UNV) et Hôpital de jour (HDJ), Service de Neurologie, CHRU de Besançon, France.

The aim of this work was to better understand the organization of conceptual tool knowledge following stroke. We explored specifically the link between manipulation kinematics and manipulation hand posture; and the link between manipulation kinematics and function relations in left brain-damaged (n = 30) and right brain-damaged (n = 30) patients. We examined the performance of brain-damaged patients in conceptual tool tasks using neuropsychological dissociations and disconnectome symptom mapping.

View Article and Find Full Text PDF

A gain-of-function mutation in zinc cluster transcription factor Rob1 drives Candida albicans adaptive growth in the cystic fibrosis lung environment.

PLoS Pathog

April 2024

Institut Pasteur de Tunis, University of Tunis El Manar, Laboratoire de Microbiologie Moléculaire, Vaccinologie et Développement Biotechnologique (LR16IPT01), Tunis, Tunisia.

Candida albicans chronically colonizes the respiratory tract of patients with Cystic Fibrosis (CF). It competes with CF-associated pathogens (e.g.

View Article and Find Full Text PDF

Introduction: Previous studies have shown benefits of productive art-activity on frail older adults' mental and physical health. In this study, we investigated the effects of art-producing activities in a hybrid format (in-person and online) in a context of lockdown compared with previous studies taking place in museums and their effects on wellbeing, quality of life, physical frailty, and apathy in older adults.

Methods: We conducted a randomized unicentric control trial on a sample of 126 seniors older than 65 years (mean age 71.

View Article and Find Full Text PDF

Purpose: To assess the likely pathogenic/pathogenic (LP/P) variants rates in Mendelian dementia genes and the moderate-to-strong risk factors rates in patients with Alzheimer disease (AD).

Methods: We included 700 patients in a prospective study and performed exome sequencing. A panel of 28 Mendelian and 6 risk-factor genes was interpreted and returned to patients.

View Article and Find Full Text PDF

[Episodic memory and Alzheimer's disease: evolution of theories and clinical assessment tools].

Geriatr Psychol Neuropsychiatr Vieil

December 2023

Université Paris-Cité, Laboratoire mémoire, cerveau et cognition (UR7536), Boulogne-Billancourt, France.

Alzheimer's disease is characterized by an impairment of episodic memory in the early stages of the disease. Neuropsychological evaluation is performed for diagnostic purposes and to personalize follow-up. However, although many tests have been developed over the last few decades, not all of them seem to be able to meet this dual challenge.

View Article and Find Full Text PDF

[Willingness to age in place and anosognosia of risks in Alzheimer's disease].

Geriatr Psychol Neuropsychiatr Vieil

September 2023

Université de Franche-Comté, UR LINC, Besançon, France, CIUSS Centre-Sud de l'Île-de-Montréal, Centre de recherche, Institut universitaire de gériatrie de Montréal, Montréal, Canada.

Alzheimer's disease leads to an alteration of decision-making abilities which may increase risk-taking behaviours, particularly associated anosognosia. Anticipating the progression of the disease raises a number of questions, particularly in relation to aging in place. Our qualitative study aimed to identify the arguments used by older patients with Alzheimer's disease when choosing a place to age.

View Article and Find Full Text PDF

It has been suggested that the outcomes of coronavirus disease 2019 (COVID-19) are better in individuals having recently received an influenza vaccine than in non-vaccinated individuals. We hypothesized that this association depends on the humoral responses against influenza viruses. We aim to assess the relationship between the humoral immunity against influenza and the 3-month all-cause mortality among hospitalized older patients with COVID-19.

View Article and Find Full Text PDF

Purpose: Olfactory identification disorder is considered a promising early biomarker of Alzheimer's disease (AD). The QUICK TODA2 can be used as a short olfactory screening tool specific for French AD patients. The selection of AD specific odorants and the design of this screening were the main objectives of this twofold study.

View Article and Find Full Text PDF

Introduction: The use of teleconsultations for mental health has drastically increased since 2020 due to the Covid19 pandemic. In the present paper, we aimed to analyze the advantages and disadvantages of teleconsultations for mental health compared to face-to-face consultations, and to provide recommendations in this domain.

Methods: The recommendations were gathered using a Delphi methodology.

View Article and Find Full Text PDF

Objective: This study investigates the possibility of adopting motor and cognitive dual-task (MCDT) approaches to identify subjects with mild cognitive impairment (MCI) and subjective cognitive impairment (SCI).

Methods: The upper and lower motor performances of 44 older adults were assessed using the SensHand and SensFoot wearable system during three MCDTs: forefinger tapping (FTAP), toe-tapping heel pin (TTHP), and walking 10 m (GAIT). We developed five pooled indices (PIs) based on these MCDTs, and we included them, along with demographic data (age) and clinical scores (Frontal Assessment Battery (FAB) scores), in five logistic regression models.

View Article and Find Full Text PDF

Pupil dilation is considered an index of cognitive effort, as the pupil typically dilates as the cognitive load increases. In this paper, we evaluated whether older adults demonstrate increased pupil size when performing tasks requiring cognitive inhibition. We invited 44 older and 44 younger adults to perform the Stroop task while their pupil dilation was recorded with eye-tracking glasses.

View Article and Find Full Text PDF

Hearing loss is a major public health problem with significant evidence correlating it with cognitive performance. Verbal fluency tests are commonly used to assess lexical access. They provide a great deal of information about a subject's cognitive function.

View Article and Find Full Text PDF

Early management of presbycusis: recommendations from the French Society of Otorhinolaryngology and Head and Neck Surgery, the French Society of Audiology, and the French Society of Geriatrics and Gerontology.

Geriatr Psychol Neuropsychiatr Vieil

May 2023

Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard-Herriot, Lyon, France, Claude-Bernard University Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France.

Introduction: Presbycusis is the physiological decrease in hearing due to advancing age and begins well before the sixth decade. These recommendations recall the principles of early diagnosis of presbycusis and the means of optimal rehabilitation as soon as the first symptoms appear.

Material And Methods: The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of ENT physicians, audiologists, geriatricians and hearing specialists from all over France.

View Article and Find Full Text PDF

Phenotype and imaging features associated with APP duplications.

Alzheimers Res Ther

May 2023

Department of Neurology and CNR-MAJ, Univ Rouen Normandie, U1245 and CHU Rouen, 76000, Rouen, France.

Background: APP duplication is a rare genetic cause of Alzheimer disease and cerebral amyloid angiopathy (CAA). We aimed to evaluate the phenotypes of APP duplications carriers.

Methods: Clinical, radiological, and neuropathological features of 43 APP duplication carriers from 24 French families were retrospectively analyzed, and MRI features and cerebrospinal fluid (CSF) biomarkers were compared to 40 APP-negative CAA controls.

View Article and Find Full Text PDF

[Early management of presbycusis: recommendations from the French Society of Otorhinolaryngology and Head and Neck Surgery, the French Society of Audiology, and the French Society of Geriatrics and Gerontology].

Geriatr Psychol Neuropsychiatr Vieil

March 2023

Service d'audiologie et d'explorations otoneurologiques, CHU de Lyon, Hôpital Édouard Herriot, Lyon, France, Université Lyon 1, Institut de l'audition, Institut Pasteur, Inserm, Paris, France.

Introduction: Presbycusis is the physiological decrease in hearing due to advancing age and begins well before the sixth decade. These recommendations recall the principles of early diagnosis of presbycusis and the means of optimal rehabilitation as soon as the first symptoms appear.

Material And Methods: The recommendations are based on a systematic analysis of the literature carried out by a multidisciplinary group of doctors and audioprosthetists from all over France.

View Article and Find Full Text PDF

Suspected neurodevelopmental disorders in adult patients of memory clinics: Start at the beginning. GREDEV proposals for clinical practice.

Rev Neurol (Paris)

April 2023

Centre Mémoire de Ressources et de Recherche, Pôle de Psychiatrie et Neurologie, CHU, Grenoble, France; Université Grenoble Alpes, Université Savoie Mont Blanc, CNRS UMR 5105, Laboratoire de Psychologie et Neurocognition (LPNC), Grenoble, France.

Neurodevelopmental disorders are frequent but underestimated in adult populations, even though the cognitive profile of those affected remains atypical throughout adulthood and the disorders can cause significant impairment in activities of daily living. Retrospective diagnosis in this population is challenging. In this article, the GREDEV (working group for the assessment of neurodevelopmental disorders in adults) proposes a brief screening questionnaire for patients with suspected neurodevelopmental disorders, a checklist to facilitate taking the patient history, a list of self-administered questionnaires, and the different key steps of diagnosing neurodevelopmental disorders in adults.

View Article and Find Full Text PDF

Validity and Performance of Blood Biomarkers for Alzheimer Disease to Predict Dementia Risk in a Large Clinic-Based Cohort.

Neurology

January 2023

From the Univ. Bordeaux (V.P.), CNRS UMR 5293, Institut des Maladies Neurodégénératives; CHU de Bordeaux (V.P.), Pôle de Neurosciences Cliniques, Centre Mémoire de Ressources et de Recherche; Univ. Bordeaux (V.B., G.C., C.D.), Inserm U1219, PHARes Team, Institut de Santé Publique, d'Epidémiologie et de Développement (ISPED); CHU Bordeaux (V.B., G.C., C.D.), CIC 1401 EC, Pôle Santé Publique; CHU de Bordeaux (I.P.), Département d'Immunologie et d'Immunogénétique; Univ. Paris-Saclay (J.-F.M.), CEA, CNRS, Baobab UMR9027, Neurospin, CATI Multicenter Neuroimaging Platform, US52, UAR 9031, Gif-sur-Yvette; Sorbonne-Université (B.D.), Service des Maladies Cognitives et Comportementales et Institut de La Mémoire et de La Maladie d'Alzheimer (IM2A), Hôpital de La Salpêtrière, AP-PH, Paris; Univ. Toulouse (P.-J.O.), Inserm U1027, Gérontopôle, Departement de Gériatrie, CHU Purpan, Toulouse; Univ. Lille (F.P.), Inserm U1171, Centre Mémoire de Ressources et de Recherche, CHU Lille, DISTAlz, Lille; Univ. Strasbourg (F.B.), CNRS, ICube Laboratory, UMR 7357, Fédération de Médecine Translationnelle de Strasbourg, Centre Mémoire de Ressources et de Recherche, Pôle de Gériatrie, Strasbourg; Univ. Paris (C.P.), Inserm U1144, Groupe Hospitalier Lariboisière Fernand-Widal, AP-HP; Univ. Paris Cité (O.H.), EA 4468, AP-HP, Hôpitaux Universitaires Paris Centre, Service de Gériatrie, Hôpital Broca; CHU de Montpellier (K.B.), Pôle de Neurosciences, Département de Neurologie, Centre Mémoire de Ressources et de Recherche, Montpellier; Univ. Aix Marseille (M.C.), Inserm UMR 1106, Institut de Neurosciences des Systèmes, Centre Mémoire de Ressources et de Recherche, Département de Neurologie et de Neuropsychologie, AP-HM, Marseille; Univ. Angers (C.A.), UPRES EA 4638, Centre Mémoire de Ressources et de Recherche, Département de Gériatrie, CHU d'Angers, Angers; Univ. Lyon (P.K.-S.), Inserm U1028, CNRS UMR5292, Centre de Recherche en Neurosciences de Lyon, Centre Mémoire Ressource et Recherche de Lyon (CMRR), Hôpital des Charpennes, Hospices Civils de Lyon; Univ. Picardie (O.G.), UR UPJV4559, Laboratoire de Neurosciences Fonctionnelles et Pathologies, Service de Neurologie, CHU Amiens; Univ. Normandie (D.W.), UNIROUEN, Inserm U1245, Departement de Neurologie, CNR-MAJ, CHU de Rouen; Centre Mémoire de Ressources et de Recherche Grenoble Arc Alpin (M.S.), Pôle de Psychiatrie et Neurologie, CHU Grenoble Alpes; CHU de Nantes (C.B.-B.), Département de Neurologie, Centre Mémoire de Ressources et Recherche, Nantes; Univ. Bordeaux (I.B.-M.), CNRS UMR 5536, Centre de Résonance Magnétique des Systèmes Biologiques, Pôle de Gérontologie Clinique, CHU de Bordeaux; and Univ. Clermont Auvergne (I.J.), CNRS, CHU Clermont-Ferrand, Centre Mémoire de Ressources et de Recherche, Service de Psychiatrie de L'Adulte A et Psychologie Médicale, Clermont Auvergne INP, Institut Pascal, Clermont-Ferrand.

Background And Objective: Blood biomarkers for Alzheimer disease (AD) have consistently proven to be associated with CSF or PET biomarkers and effectively discriminate AD from other neurodegenerative diseases. Our aim was to test their utility in clinical practice, from a multicentric unselected prospective cohort where patients presented with a large spectrum of cognitive deficits or complaints.

Methods: The MEMENTO cohort enrolled 2,323 outpatients with subjective cognitive complaint (SCC) or mild cognitive impairment (MCI) consulting in 26 French memory clinics.

View Article and Find Full Text PDF

Brain Metabolic Profile in Presymptomatic Carriers Throughout a 5-Year Follow-up.

Neurology

January 2023

From the Sorbonne Université (D.S., L.S., M.H., A.F., D.R., M.L., R.M., I.L.B.), Paris Brain Institute-Institut du Cerveau-ICM, Inserm U1127, CNRS UMR 7225, Paris, France; IM2A (D.S., M.H., A.F., D.R., C.A., R.M., I.L.B.), Reference Centre for Rare or Early-Onset Dementias, Département de Neurologie, AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Aramis Project Team (D.S.), Inria Research Center of Paris, France; Sorbonne Université (H.B., M.P.-I., M.L., A.K., M.-O.H.), CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, LIB, Paris, France; Centre d'Acquisition et de Traitement d'Images (CATI) (H.B., M.L., A.K., M.-O.H.), US52-UAR2031, CEA, ICM, SU, CNRS, INSERM, APHP, Ile de France, France; Université Paris-Saclay (H.B.), CEA, CNRS, Neurospin, UMR9027 Baobab, Gif-sur-Yvette, France; Centre of Excellence of Neurodegenerative Disease (CoEN) (M.H.), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Département de Médecine Nucléaire (V.C.-L., A.K., M.-O.H.), AP-HP - Hôpital Pitié-Salpêtrière, Paris, France; Nuclear Medicine Department (A.J.), CHU Lille, Lille, France; Univ Lille (F.P.), Inserm U1172, CHU Lille, DistAlz, LiCEND, CNR-MAJ, France; Department of Nuclear Medicine (M.C.), Centre Henri Becquerel, Rouen University Hospital, France; Normandie Univ (D.W.), UNIROUEN, Inserm U1245 and CHU Rouen, Department of Neurology, CNR-MAJ, Normandy Center for Genomic and Personalized Medicine, CIC-CRB1404, Rouen, France; Nuclear Medicine Department (A.H.), Toulouse Purpan University Hospital, France; Department of Neurology and ToNIC (J.P.), Toulouse NeuroImaging Centre, Inserm, UPS, Toulouse University Hospital, France; Nuclear Medicine Department (A.P.), University Hospital of Nantes, France; CHU Nantes (C.B.-B.), Inserm CIC04, Department of Neurology, Centre Mémoire de Ressources et Recherche, Nantes, France; Nuclear Medicine Department (E.G.), Aix-Marseille University, APHM, CNRS, Centrale Marseille, Institut Fresnel, Timone Hospital, CERIMED, France; APHM (M.D.), Timone, Service de Neurologie et Neuropsychologie, APHM-Hôpital Timone Adultes, Marseille, France; and Aix-Marseille Univ (M.D.), INSERM, INS Institut de Neurosciences des Systèmes, France.

Background And Objectives: variants are a frequent cause of familial frontotemporal dementia (FTD). Monitoring disease progression in asymptomatic carriers of genetic variants is a major challenge in delivering preventative therapies before clinical onset. This study aimed to assess the usefulness of fluorodeoxyglucose (FDG)-PET in identifying metabolic changes in presymptomatic carriers (PS-+) and to trace their longitudinal progression.

View Article and Find Full Text PDF